Efficacy of additional ExTRa Mapping‐guided substrate ablation beyond pulmonary vein isolation in persistent atrial fibrillation: The ROTATE trial
Journal of Cardiovascular Electrophysiology · 2025-08 · 36 (8) · 1999-2010
DOI: 10.1111/jce.16772 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 23.06.2025. Verfasst von Tetsuma Kawaji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation, Electrophysiologic Techniques, Cardiac. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
There are currently no established effective additional substrate ablation strategies beyond pulmonary vein isolation (PVI) for persistent atrial fibrillation (AF).
Objective
This randomized clinical trial evaluated the efficacy of a novel substrate ablation technique using the ExTRa Mapping system, which visualizes rotational activation during AF rhythm.
Methods
This study included 80 patients undergoing initial catheter ablation for persistent AF. Eighty patients whose AF persisted after PVI and ExTRa Mapping were randomly assigned in a 1:1 ratio to either PVI alone or PVI plus ExTRa Mapping‐guided substrate ablation targeting areas with high non‐passively activated ratio(%NP)( ≥ 35%)(ExTRa group). The primary outcome measure was recurrence of atrial tachyarrhythmias after a 90‐day blanking period postablation.
Results
Post‐PVI ExTRa Mapping assessed a median of 36 sites per patient in both atria. Baseline characteristics were comparable between groups. The ExTRa group showed higher event‐free survival from the primary outcome compared to the PVI alone group (85.0% vs . 67.5% at 1‐year, p = 0.07). This favorable prognosis was more pronounced for patients with a large( ≥ 12 sites) area of rotational activation area (81.0% vs. 57.9% at 1‐year, p = 0.01). Multivariable analysis identified the number of high %NP areas as an independent risk factor for recurrent tachyarrhythmias (HR 1.13, 95%CI 1.03–1.23, p = 0.005), while ExTRa Mapping‐guided substrate ablation emerged as a unique protective factor (HR 0.38, 95%CI 0.13‐0.99, p = 0.047).
Conclusion
While the reduction in atrial tachyarrhythmia recurrence of persistent AF patients did not reach statistical significance, the addition of ExTRa Mapping™‐guided substrate ablation beyond PVI demonstrated promising potential, especially in patients with larger rotational activation areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto.
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto.
ORCID-Profile: Tetsuma Kawaji, Satoshi Shizuta, Takafumi Yokomatsu
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Kawaji, T., Aizawa, T., Shizuta, S., Yamano, S., Naka, M., Bao, B., Hojo, S., Matsuda, S., Kato, M., Yokomatsu, T., & Miki, S. (2025). Efficacy of additional ExTRa Mapping‐guided substrate ablation beyond pulmonary vein isolation in persistent atrial fibrillation: The ROTATE trial. Journal of Cardiovascular Electrophysiology, 36(8), 1999-2010. https://doi.org/10.1111/jce.16772
Vancouver
Kawaji T, Aizawa T, Shizuta S, Yamano S, Naka M, Bao B, et al. Efficacy of additional ExTRa Mapping‐guided substrate ablation beyond pulmonary vein isolation in persistent atrial fibrillation: The ROTATE trial. Journal of Cardiovascular Electrophysiology. 2025;36(8):1999-2010. doi:10.1111/jce.16772
BibTeX
@article{Kawaji2025,
author = {Kawaji, Tetsuma and Aizawa, Takanori and Shizuta, Satoshi and Yamano, Saki and Naka, Misaki and Bao, Bingyuan and Hojo, Shun and Matsuda, Shintaro and Kato, Masashi and Yokomatsu, Takafumi and Miki, Shinji},
title = {Efficacy of additional ExTRa Mapping‐guided substrate ablation beyond pulmonary vein isolation in persistent atrial fibrillation: The ROTATE trial},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
volume = {36},
number = {8},
pages = {1999--2010},
doi = {10.1111/jce.16772}
}
EUVIMED